Skip to main content
Erschienen in: Osteoporosis International 2/2007

01.02.2007 | Review

Anti-epileptic medication and bone health

verfasst von: S. J. Petty, T. J. O’Brien, J. D. Wark

Erschienen in: Osteoporosis International | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Epilepsy is a common chronic neurological disorder, usually requiring long-term treatment with anti-epileptic drugs (AED). Many studies have reported that AED therapy is associated with metabolic bone disease and is a major iatrogenic risk factor for fractures. There remains uncertainty about the type(s) of bone disease due to AED treatment, and the pathogenesis of AED-associated fractures.

Rationale

Deficits in bone mineral density (BMD) are widely reported in AED-treated patient populations. However, much of the research conducted to date has been limited by factors such as small sample size, potentially biased subject selection, a lack of selection of appropriate control data, and failure to take account of important confounding influences. The pathogenesis of AED-associated fractures is likely to be multifactorial, due to factors including reduced BMD, impaired bone quality (due to osteoporosis and/or osteomalacia), increased propensity to fall, and fractures associated with seizures or loss of consciousness.

Recommendations

Patients receiving long-term AED should be monitored for indices of bone health, including BMD and vitamin D status. Lifestyle factors should be optimized, vitamin D status maintained, and fall prevention strategies introduced as appropriate. Good seizure control is important. The use of additional, specific osteoporosis therapy is not evidence-based in this setting, but would appear reasonable in patients with clinically significant decreases in BMD, applying current treatment guidelines for osteoporosis.

Conclusion

There is a pressing need for improved understanding of the pathogenesis of AED-associated bone disease, for better definition of the risk associated with specific AED regimens, and for the development of evidence-based preventive and treatment approaches in this common but neglected disorder.
Literatur
1.
2.
Zurück zum Zitat Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA (2002) Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 43(11):1402–1409PubMedCrossRef Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA (2002) Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 43(11):1402–1409PubMedCrossRef
3.
Zurück zum Zitat Kruse R (1968) [Osteopathies in antiepileptic long-term therapy (preliminary report)] (in German). Monatsschr Kinderheilkd 116(6):378–381PubMed Kruse R (1968) [Osteopathies in antiepileptic long-term therapy (preliminary report)] (in German). Monatsschr Kinderheilkd 116(6):378–381PubMed
4.
Zurück zum Zitat Schmid F (1967) Osteopathien bei antiepileptischer Dauerbehandlung. Fortschr Med 85:381–382 Schmid F (1967) Osteopathien bei antiepileptischer Dauerbehandlung. Fortschr Med 85:381–382
5.
Zurück zum Zitat Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58(9):1369–1374PubMedCrossRef Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58(9):1369–1374PubMedCrossRef
6.
Zurück zum Zitat Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 4(781):202–204PubMed Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J 4(781):202–204PubMed
7.
Zurück zum Zitat Richens A, Rowe DJ (1970) Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J 4(727):73–76PubMed Richens A, Rowe DJ (1970) Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J 4(727):73–76PubMed
8.
Zurück zum Zitat Lifshitz F, Maclaren NK (1973) Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr 83(4):612–620PubMedCrossRef Lifshitz F, Maclaren NK (1973) Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr 83(4):612–620PubMedCrossRef
9.
Zurück zum Zitat Christiansen C, Kristensen M, Rodbro P (1972) Latent osteomalacia in epileptic patients on anticonvulsants. Br Med J 3(829):738–739PubMedCrossRef Christiansen C, Kristensen M, Rodbro P (1972) Latent osteomalacia in epileptic patients on anticonvulsants. Br Med J 3(829):738–739PubMedCrossRef
10.
Zurück zum Zitat Strasser F, Driver L, Burton A (2003) Update on adjuvant medications for chronic nonmalignant pain. Pain Practice 3(4):282–297PubMedCrossRef Strasser F, Driver L, Burton A (2003) Update on adjuvant medications for chronic nonmalignant pain. Pain Practice 3(4):282–297PubMedCrossRef
11.
Zurück zum Zitat Vasconcelos D (1973) Compression fractures of the vertebrae during major epileptic seizures. Epilepsia 14(3):323–328PubMed Vasconcelos D (1973) Compression fractures of the vertebrae during major epileptic seizures. Epilepsia 14(3):323–328PubMed
12.
Zurück zum Zitat Mattson RH, Gidal BE (2004) Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 5(Suppl 2):S36–S40PubMedCrossRef Mattson RH, Gidal BE (2004) Fractures, epilepsy, and antiepileptic drugs. Epilepsy Behav 5(Suppl 2):S36–S40PubMedCrossRef
13.
Zurück zum Zitat van Staa TP, Leufkens HG, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31(4):508–514PubMedCrossRef van Staa TP, Leufkens HG, Cooper C (2002) Utility of medical and drug history in fracture risk prediction among men and women. Bone 31(4):508–514PubMedCrossRef
14.
Zurück zum Zitat Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332(12):767–773PubMedCrossRef Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332(12):767–773PubMedCrossRef
15.
Zurück zum Zitat Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR (1993) Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118(9):657–665PubMed Bauer DC, Browner WS, Cauley JA, Orwoll ES, Scott JC, Black DM, Tao JL, Cummings SR (1993) Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 118(9):657–665PubMed
16.
Zurück zum Zitat Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62(11):2051–2057PubMed Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62(11):2051–2057PubMed
17.
Zurück zum Zitat Lidgren L, Walloe A (1977) Incidence of fracture in epileptics. Acta Orthop Scand 48(4):356–361PubMedCrossRef Lidgren L, Walloe A (1977) Incidence of fracture in epileptics. Acta Orthop Scand 48(4):356–361PubMedCrossRef
18.
Zurück zum Zitat Stephen LJ, McLellan AR, Harrison JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ (1999) Bone density and antiepileptic drugs: a case-controlled study. Seizure 8(6):339–342PubMedCrossRef Stephen LJ, McLellan AR, Harrison JH, Shapiro D, Dominiczak MH, Sills GJ, Brodie MJ (1999) Bone density and antiepileptic drugs: a case-controlled study. Seizure 8(6):339–342PubMedCrossRef
19.
Zurück zum Zitat Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L (1999) Fracture risk is increased in epilepsy. Acta Neurol Scand 99(5):269–275PubMedCrossRef Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L (1999) Fracture risk is increased in epilepsy. Acta Neurol Scand 99(5):269–275PubMedCrossRef
20.
Zurück zum Zitat Souverein P, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T (2005) Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 46(2):304–310PubMedCrossRef Souverein P, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T (2005) Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 46(2):304–310PubMedCrossRef
21.
Zurück zum Zitat Koppel BS, Harden CL, Nikolov BG, Labar DR (2005) An analysis of lifetime fractures in women with epilepsy. Acta Neurol Scand 111(4):225–228PubMedCrossRef Koppel BS, Harden CL, Nikolov BG, Labar DR (2005) An analysis of lifetime fractures in women with epilepsy. Acta Neurol Scand 111(4):225–228PubMedCrossRef
22.
Zurück zum Zitat Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk—a meta-analysis. Acta Neurol Scand 112(5):277–286PubMedCrossRef Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk—a meta-analysis. Acta Neurol Scand 112(5):277–286PubMedCrossRef
23.
Zurück zum Zitat Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr 127(2):256–262PubMedCrossRef Sheth RD, Wesolowski CA, Jacob JC, Penney S, Hobbs GR, Riggs JE, Bodensteiner JB (1995) Effect of carbamazepine and valproate on bone mineral density. J Pediatr 127(2):256–262PubMedCrossRef
24.
Zurück zum Zitat Kafali G, Erselcan T, Tanzer F (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila) 38(2):93–98CrossRef Kafali G, Erselcan T, Tanzer F (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila) 38(2):93–98CrossRef
25.
Zurück zum Zitat Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58(9):1348–1353PubMed Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58(9):1348–1353PubMed
26.
Zurück zum Zitat Pluskiewicz W, Nowakowska J (1997) Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges. Ultrasound Med Biol 23(4):553–558PubMedCrossRef Pluskiewicz W, Nowakowska J (1997) Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges. Ultrasound Med Biol 23(4):553–558PubMedCrossRef
27.
Zurück zum Zitat Hahn TJ, Hendin BA, Scharp CR, Boisseau BA, Haddad JG Jr (1975) Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 292(11):550–554CrossRef Hahn TJ, Hendin BA, Scharp CR, Boisseau BA, Haddad JG Jr (1975) Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. N Engl J Med 292(11):550–554CrossRef
28.
Zurück zum Zitat Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB (1984) Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 58(6):1003–1009PubMedCrossRef Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB (1984) Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 58(6):1003–1009PubMedCrossRef
29.
Zurück zum Zitat Guo CY, Ronen GM, Atkinson SA (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42(9):1141–1147PubMedCrossRef Guo CY, Ronen GM, Atkinson SA (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 42(9):1141–1147PubMedCrossRef
30.
Zurück zum Zitat Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsukahara Y, Miura M, Mayumi M (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 44(3):247–253PubMedCrossRef Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsukahara Y, Miura M, Mayumi M (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int 44(3):247–253PubMedCrossRef
31.
Zurück zum Zitat Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E (1998) Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 19(2):129–131PubMedCrossRef Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E (1998) Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 19(2):129–131PubMedCrossRef
32.
Zurück zum Zitat Oner N, Kaya M, Karasalihoglu S, Karaca H, Celtik C, Tutunculer F (2004) Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health 40(8):470–473PubMedCrossRef Oner N, Kaya M, Karasalihoglu S, Karaca H, Celtik C, Tutunculer F (2004) Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health 40(8):470–473PubMedCrossRef
33.
Zurück zum Zitat Verrotti A, Greco R, Morgese G, Chiarelli F (2000) Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 47(3):385–388PubMedCrossRef Verrotti A, Greco R, Morgese G, Chiarelli F (2000) Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 47(3):385–388PubMedCrossRef
34.
Zurück zum Zitat Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43(12):1488–1492PubMedCrossRef Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 43(12):1488–1492PubMedCrossRef
35.
Zurück zum Zitat Kroger H, Kotaniemi A, Vainio P, Alhava E (1992) Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner 17(1):75–85PubMedCrossRef Kroger H, Kotaniemi A, Vainio P, Alhava E (1992) Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner 17(1):75–85PubMedCrossRef
36.
Zurück zum Zitat Ecevit C, Aydogan A, Kavakli T, Altinoz S (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31(4):279–282PubMedCrossRef Ecevit C, Aydogan A, Kavakli T, Altinoz S (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 31(4):279–282PubMedCrossRef
37.
Zurück zum Zitat Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A (2000) Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 13(7):933–939PubMed Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A (2000) Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 13(7):933–939PubMed
38.
Zurück zum Zitat Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57(3):445–449PubMed Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 57(3):445–449PubMed
39.
Zurück zum Zitat Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N (1986) A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 59(230):569–577PubMed Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N (1986) A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 59(230):569–577PubMed
40.
Zurück zum Zitat Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA (2000) Long-term anticonvulsant therapy leads to low bone mineral density—evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 108(1):37–43PubMed Feldkamp J, Becker A, Witte OW, Scharff D, Scherbaum WA (2000) Long-term anticonvulsant therapy leads to low bone mineral density—evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp Clin Endocrinol Diabetes 108(1):37–43PubMed
41.
Zurück zum Zitat Valimaki MJ, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, Makela P, Tunninen R (1994) Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 9(5):631–637PubMedCrossRef Valimaki MJ, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, Makela P, Tunninen R (1994) Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 9(5):631–637PubMedCrossRef
42.
Zurück zum Zitat Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A (2004) The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 50(1):93–97PubMedCrossRef Boluk A, Guzelipek M, Savli H, Temel I, Ozisik HI, Kaygusuz A (2004) The effect of valproate on bone mineral density in adult epileptic patients. Pharmacol Res 50(1):93–97PubMedCrossRef
43.
Zurück zum Zitat Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59(5):781–786PubMedCrossRef Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59(5):781–786PubMedCrossRef
44.
Zurück zum Zitat Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E (2003) Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 4(2):169–174CrossRef Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E (2003) Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 4(2):169–174CrossRef
45.
Zurück zum Zitat Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E (2005) Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57(2):252–257PubMedCrossRef Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, Randall A, Seale C, Shane E (2005) Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 57(2):252–257PubMedCrossRef
46.
Zurück zum Zitat Petty SJ, Paton LM, O’Brien TJ, Makovey J, Erbas B, Sambrook P, Berkovic SF, Wark JD (2005) Effect of antiepileptic medication on bone mineral measures. Neurology 65(9):1358–1365PubMedCrossRef Petty SJ, Paton LM, O’Brien TJ, Makovey J, Erbas B, Sambrook P, Berkovic SF, Wark JD (2005) Effect of antiepileptic medication on bone mineral measures. Neurology 65(9):1358–1365PubMedCrossRef
47.
Zurück zum Zitat Fitzpatrick LA (2004) Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 5(Suppl 2):S3–S15PubMedCrossRef Fitzpatrick LA (2004) Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 5(Suppl 2):S3–S15PubMedCrossRef
48.
Zurück zum Zitat Wark JD, Larkins RG, Perry-Keene D, Peter CT, Ross DL, Sloman JG (1979) Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D. Clin Endocrinol (Oxf) 11(3):267–274 Wark JD, Larkins RG, Perry-Keene D, Peter CT, Ross DL, Sloman JG (1979) Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D. Clin Endocrinol (Oxf) 11(3):267–274
49.
Zurück zum Zitat Koch HU, Kraft D, von Herrath D, Schaefer K (1972) Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 13(6):829–834PubMed Koch HU, Kraft D, von Herrath D, Schaefer K (1972) Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat. Epilepsia 13(6):829–834PubMed
50.
Zurück zum Zitat Shane E (1996) Osteoporosis associated with illness and medications. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York Shane E (1996) Osteoporosis associated with illness and medications. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York
51.
Zurück zum Zitat Rattya J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllyla VV, Isojarvi JI (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57(3):440–444PubMed Rattya J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllyla VV, Isojarvi JI (2001) Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57(3):440–444PubMed
52.
Zurück zum Zitat Bjorholt PG, Nakken KO, Rohme K, Hansen H (1990) Leisure time habits and physical fitness in adults with epilepsy. Epilepsia 31(1):83–87PubMed Bjorholt PG, Nakken KO, Rohme K, Hansen H (1990) Leisure time habits and physical fitness in adults with epilepsy. Epilepsia 31(1):83–87PubMed
53.
Zurück zum Zitat Morrell MJ (2003) Reproductive and metabolic disorders in women with epilepsy. Epilepsia 44(Suppl 4):11–20PubMedCrossRef Morrell MJ (2003) Reproductive and metabolic disorders in women with epilepsy. Epilepsia 44(Suppl 4):11–20PubMedCrossRef
54.
Zurück zum Zitat Death AK, McGrath KC, Handelsman DJ (2005) Valproate is an anti-androgen and anti-progestin. Steroids 70(14):946–953PubMedCrossRef Death AK, McGrath KC, Handelsman DJ (2005) Valproate is an anti-androgen and anti-progestin. Steroids 70(14):946–953PubMedCrossRef
55.
Zurück zum Zitat Johnell O, Nilsson BE, Walloe A, Wiklund PE (1979) Bone morphology in epileptics. Calcif Tissue Int 28(2):93–97PubMedCrossRef Johnell O, Nilsson BE, Walloe A, Wiklund PE (1979) Bone morphology in epileptics. Calcif Tissue Int 28(2):93–97PubMedCrossRef
56.
Zurück zum Zitat Elliott JO, Jacobson MP (2006) Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsy Behav 8(1):169–175PubMedCrossRef Elliott JO, Jacobson MP (2006) Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsy Behav 8(1):169–175PubMedCrossRef
57.
Zurück zum Zitat Harden CL (2003) Menopause and bone density issues for women with epilepsy. Neurology 61(6 Suppl 2):S16–S22PubMed Harden CL (2003) Menopause and bone density issues for women with epilepsy. Neurology 61(6 Suppl 2):S16–S22PubMed
58.
59.
Zurück zum Zitat Heller HJ, Sakhaee K (2001) Anticonvulsant-induced bone disease: a plea for monitoring and treatment. Arch Neurol 58(9):1352–1353PubMedCrossRef Heller HJ, Sakhaee K (2001) Anticonvulsant-induced bone disease: a plea for monitoring and treatment. Arch Neurol 58(9):1352–1353PubMedCrossRef
60.
Zurück zum Zitat Collins N, Maher J, Cole M, Baker M, Callaghan N (1991) A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 78(286):113–122PubMed Collins N, Maher J, Cole M, Baker M, Callaghan N (1991) A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 78(286):113–122PubMed
61.
Zurück zum Zitat Pedrera JD, Canal ML, Carvajal J, Postigo S, Villa LF, Hernandez ER, Rico H (2000) Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest 30(10):895–899PubMedCrossRef Pedrera JD, Canal ML, Carvajal J, Postigo S, Villa LF, Hernandez ER, Rico H (2000) Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest 30(10):895–899PubMedCrossRef
62.
Zurück zum Zitat Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47PubMedCrossRef Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47PubMedCrossRef
Metadaten
Titel
Anti-epileptic medication and bone health
verfasst von
S. J. Petty
T. J. O’Brien
J. D. Wark
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 2/2007
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-006-0185-z

Weitere Artikel der Ausgabe 2/2007

Osteoporosis International 2/2007 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.